PTJ
DYN icon

Paul Tudor Jones’s Dyne Therapeutics DYN Stock Holding History

Paul Tudor Jones’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-77,031
Closed -$1.4M – 3735
2026
Q1 		$1.4M Sell
77,031
-70,590
-48% -$1.22M ﹤0.01% 2127
2025
Q4 		$2.89M Buy
+147,621
New +$2.8M 0.01% 1541
2025
Q2 		– Sell
-81,266
Closed -$850K – 3364
2025
Q1 		$850K Buy
81,266
+38,002
+88% +$544K ﹤0.01% 1921
2024
Q4 		$1.02M Sell
43,264
-7,219
-14% -$214K ﹤0.01% 1715
2024
Q3 		$1.81M Buy
50,483
+3,414
+7% +$136K 0.01% 1256
2024
Q2 		$1.66M Sell
47,069
-9,892
-17% -$287K 0.01% 1177
2024
Q1 		$1.62M Buy
+56,961
New +$1.29M 0.01% 1121
2023
Q2 		– Sell
-61,003
Closed -$703K – 2546
2023
Q1 		$703K Buy
61,003
+746
+1% +$9.69K 0.01% 1412
2022
Q4 		$698K Buy
60,257
+34,057
+130% +$394K 0.01% 1360
2022
Q3 		$333K Sell
26,200
-43,863
-63% -$503K 0.01% 1714
2022
Q2 		$481K Buy
70,063
+14,932
+27% +$103K 0.01% 1290
2022
Q1 		$531K Buy
55,131
+16,016
+41% +$136K 0.01% 1239
2021
Q4 		$465K Buy
+39,115
New +$550K 0.01% 1531
2021
Q3 		– Sell
-23,230
Closed -$489K – 2526
2021
Q2 		$489K Sell
23,230
-50,528
-69% -$950K 0.01% 1171
2021
Q1 		$1.15M Buy
73,758
+62,992
+585% +$1.22M 0.02% 773
2020
Q4 		$226K Sell
10,766
-2,708
-20% -$53.6K 0.01% 1202
2020
Q3 		$272K Buy
+13,474
New +$296K 0.01% 1022

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Paul Tudor Jones's DYN Position: Q2 2026 in Review

Paul Tudor Jones sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 77,031 shares — an estimated $1.4M sold.

Paul Tudor Jones first reported a position in DYN in Q3 2020 and held it in 17 quarters. The position peaked at $2.89M in Q4 2025. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Paul Tudor Jones reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 77,031 Dyne Therapeutics shares in Q2 2026, an estimated $1.4M.
  • Paul Tudor Jones first reported a position in Dyne Therapeutics in Q3 2020 and held it in 17 quarters.
  • Paul Tudor Jones's Dyne Therapeutics position peaked at $2.89M in Q4 2025.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.